Princeton, NJ – Kenox Pharmaceuticals Inc. (Kenox) is excited to announce a new strategic partnership with Strides Pharma Science Ltd. The collaboration will strengthen Strides’ pipeline of nasal spray products across a wide range of therapeutic areas. Kenox brings deep expertise in formulation and development of Orally Inhaled and Nasal Drug Products (OINDPs). Strides adds robust commercial and manufacturing capabilities to advance the development and filing of multiple nasal spray products.
Together, we aim to deliver affordable, high-quality nasal spray medicines to patients in need. This milestone underscores Kenox’s leadership in OINDPs and marks an important step in our growth journey.
Read the full press releases:
Kenox Press Release Click here.
Strides Press Release Click here.
If you would like to discuss your project or learn more about our capabilities, please reach out to us at bd@kenoxpharma.us.